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Abstract Human chorionic gonadotropin (hCG) is a
pregnancy hormone secreted by the placental synctiotro-
phoblast cell layer that has been linked to fetal growth and
various placental, uterine and fetal functions. In order to
investigate the effects of hCG on clinical endpoints,
knowledge on reference range (RR) methodology and de-
terminants of gestational hCG levels is crucial. Moreover, a
better understanding of gestational hCG physiology can
improve current screening programs and future clinical
management. Serum total hCG levels were determined in
8195 women participating in the Generation R Study.
Gestational age specific RRs using ‘ultrasound derived
gestational age’ (US RRs) were calculated and compared
with ‘last menstrual period derived gestational age’ (LMP
RRs) and a model-based RR. We also investigated which
pregnancy characteristics were associated with hCG levels.
Compared to the US RRs, the LMP RRs were lower, most
notably for the median and lower limit levels. No consid-
erable differences were found between RRs calculated in
the general population or in uncomplicated pregnancies
only. Maternal smoking, BMI, parity, ethnicity, fetal gen-
der, placental weight and hyperemesis gravidarum symp-
toms were associated with total hCG. We provide
gestational RRs for total hCG and show that total hCG
values and RR cut-offs during pregnancy vary depending
on pregnancy dating methodology. This is likely due to the
influence of hCG on embryonic growth, suggesting that
ultrasound based pregnancy dating might be less reliable in
women with high/low hCG levels. Furthermore, we iden-
tify different pregnancy characteristics that influence total
hCG levels considerably and should therefore be accounted
for in clinical studies.
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Introduction
Human chorionic gonadotropin (hCG) is a pregnancy
hormone secreted by the placental synctiotrophoblast cell
layer. hCG levels have a very typical trajectory during
pregnancy. hCG levels increase exponentially during very
early pregnancy, after reaching a plateau during the late
first trimester hCG levels steadily decline until a steady
state which is seen throughout the second and third tri-
mesters. Classically, hCG is known for maintaining the
corpus luteum and its progesterone production, which is
essential for embryo implantation [1–3]. Various types of
studies have linked hCG to other placental, uterine and
fetal functions such as umbilical cord development, sup-
pression of myometrial contractions, the promotion of
growth and differentiation of fetal organs but also angio-
genesis and regulation of immune tolerance [4]. Although
the main clinical utility of hCG levels lies within early
pregnancy, these findings underline the importance of hCG
throughout gestational physiology and suggest that varia-
tions in hCG levels may be associated with adverse clinical
outcomes.
Indeed, abnormal levels of hCG have previously been
associated with adverse pregnancy outcomes such as fetal
loss, preeclampsia, preterm delivery and fetal growth re-
striction [5–10]. In order to study such clinical asso-
ciations, it is essential to establish correct gestational age-
dependent reference ranges (RRs) which can be difficult
because hCG itself has been proposed as a marker of
gestational age [11]. hCG has been shown to be and to
determine confounding and mediating factors such as dif-
ferences between different measurement methodologies,
pregnancy dating methodologies and differences in
population characteristics [12–15]. The latter is especially
important because previous studies have demonstrated that
certain maternal or fetal characteristics, such as maternal
smoking, parity, ethnicity, body-mass index (BMI), pla-
cental weight, hyperemesis gravidarum symptoms and fetal
gender, that are associated with an increased risk of ad-
verse pregnancy outcomes, are also associated with hCG
levels [16–23].
This study aims to identify determinants of hCG levels
during pregnancy that play a role in the complex rela-
tionship between hCG and clinical outcomes. We investi-
gated in a large prospective-based cohort study the
difference between RRs calculated according to pregnancy
dating by ultrasound (US RRs) and RRs determined ac-
cording to last menstrual period (LMP RRs). In addition,
we compared reference range determination by a sensitive
model-based approach with the more conventional non-
parametric approach and studied if total hCG RRs deter-
mined in the general population are different from RRs
calculated in uncomplicated pregnancies only. Further-
more, we analyzed which maternal and fetal characteristic
are associated with total hCG levels.
Materials and methods
Study population
This study was embedded in the Generation R Study, a
population-based prospective cohort from early fetal life
onwards in Rotterdam, The Netherlands [24].
In 8195 pregnant women, total serum hCG levels were
determined from blood samples drawn from the women at
inclusion in the study (median 14.4 weeks; 95 % range
10.1–26.2). Women with a late termination of pregnancy
(TOP) were excluded from the study population (n = 2).
For population-based RR, and total hCG determinant
analyses, women with twin pregnancies (n = 90) or
in vitro fertilization treatment (n = 38) were excluded
(Supplemental Table 5).
Serum measurements
hCG was analyzed in serum using a solid-phase two-site
chemiluminescent immunometric assay, calibrated against
WHO 3rd IS 75/537, on an Immulite 2000 XPi system
(Siemens Healthcare Diagnostics, Deerfield, IL, USA). The
Siemens assay detects serum intact hCG, hyperglycosy-
lated hCG, serum nicked hCG, serum nicked hyperglyco-
sylated hCG, serum asialo hCG, serum hCG free b-subunit
and serum nicked hCG b [25]. The inter assay coefficient
of variation was 8.0, 6.3 and 5.1 % at the concentration of
9.7, 53.1 and 821.5 IU/L, respectively. Although the Im-
mulite 2000 is considered as one of the best assays for total
hCG, it should be noted that the reference ranges in this
paper are assay specific and do not correspond with hCG
values obtained from different assays [26].
Covariates
Ultrasound examinations were performed using an Aloka
model SSD-1700 (Tokyo, Japan) or the ATL-Philips
Model HDI 5000 (Seattle, WA, USA). Fetal biometry
consisting of BPD (outer–outer), HC, TCD, AC and FL
was measured during each ultrasound examination. CRL
was measured in early pregnancy if feasible and Verburg’s
equation was used to transform CRL to gestational age
[27]. CRL was measured in a true mid-sagittal plane with
the genital tubercle and the fetal spine longitudinally in
view. The maximum length from cranium to the caudal
rump was measured as a straight line. BPD and HC were
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measured in a transverse section of the head with a central
midline echo, interrupted in the anterior third by the cavity
of the septum pellucidum with the anterior and posterior
horns of the lateral ventricles in view. For BPD the outer–
outer diameter was measured perpendicular to the midline
and for HC an ellipse was drawn around the outline of the
skull. For the TCD measurement the transducer was rotated
from the transverse plane for measurement of the BPD
towards the cerebellum in the back of the head while
keeping the cavity of the septum pellucidum in view. The
optimal plane was reached when the peduncles were vi-
sualized with a symmetrical shaped cerebellum. The cali-
pers were placed on the outer, lateral edges of the
cerebellum. AC was measured in a symmetrical, trans-
verse, round section through the abdomen, with visualiza-
tion of the vertebrae on a lateral position in alignment with
the ribs. The measurement was taken in a plane with the
stomach and the bifurcation of the umbilical and hepatic
veins using an ellipse around the abdomen. FL was mea-
sured with the full length of the bone in view perpendicular
to the ultrasound beam. Transvaginal scanning was per-
formed in case of limited visibility by transabdominal
scanning in early pregnancy.
Quality checks were carried out frequently to assess the
correctness of the ultrasound sections used for biometry
measurements and placements of the calipers. Feedback
was provided when needed to optimize individual perfor-
mance. As experience in early pregnancy is limited, in-
traobserver and interobserver reproducibility of fetal
ultrasound measurements from 9 to 14 weeks of gestation
was assessed in 21 pregnancies. The intraclass correlation
coefficient (ICC) and coefficient of variation (CV) were
calculated. The ICC was higher than 0.98 and the corre-
sponding CV lower than 6 % for all fetal biometry pa-
rameters. Bland and Altman plots to test agreement of
measurements for fetal biometry demonstrated normal
distributions; the mean difference was around zero and
95 % of measurements fell within 2SD of the mean. The
95 % limits of agreement for differences in fetal biometry
measurements between and among operators in proportions
fell within 10 % of the mean of the measurements, indi-
cating good reproducibility [27].
Last menstrual period (LMP) was obtained from the
referring letter from the community midwife or hospital.
This date was confirmed with the mother at the ultrasound
visit and additional information on the regularity and cycle
duration was obtained. A subset of 2948 women included
during early pregnancy were selected for ascertainment of
LMP gestational age, subsequently women with neither a
known first day of the last menstrual period nor a regular
menstrual cycle of 28 plus or minus 4 days were excluded
(n = 1431). In case of a discrepant result between the LMP
obtained from hospital/midwife letters and self-reported
LMP at the research center, the LMP closest to the gesta-
tional age based on CRL measurement was used. Infor-
mation on maternal age, parity, ethnicity, education and
smoking status was obtained by questionnaires during
pregnancy. Information on fertility treatment, mode of
delivery, pregnancy outcome, date of birth, birth anthro-
pometrics, and child gender were obtained from commu-
nity midwives, obstetricians, and hospital registries [24].
Statistical analysis
Non-parametric gestational age specific RRs were deter-
mined by the 2.5th–97.5th percentiles for each gestational
week. In order to compare total hCG values throughout
gestation, multiple of median (MoM) values were calculated
by dividing each participant’s total hCG level with the
median value of the total group for that particular gestational
week. Model-based reference ranges were created using
Generalized Additive Models for Location, Size and Shape
(GAMLSS). These specific statistical tools enable flexible,
(semi) parametric, RR calculations while accounting for
skewness and kurtosis of the data during the modelling
process. We used 15 cubic splines for gestational age at
blood sampling, 3 cubic splines for sigma variation and a
Box Cox t family distribution (after sensitivity analyses
using Akaike Information Criterion and worm plots) in order
to achieve the best fit, while also accounting for the known,
typical pregnancy hCG trajectory [28]. Subsequently, ges-
tational age specific Z-scores were derived from the model.
In order to compare the model cut-off values to the non-
parametric cut-off values (calculated per week), 2.5th, 50th
and 97.5th values calculated for the middle of each week
were derived from the model.
Because hCG may influence early fetal growth, gesta-
tional age that is defined according to fetal growth (US
RRs) may differ according to hCG levels. For this reason,
we also defined gestational age according to the first day of
the LMP in a subgroup of mothers with data available on
LMP that had a regular menstrual cycle (28 plus or minus
4 days; n = 1526) [29, 30].
As hCG levels may differ in complicated pregnancies,
RRs were also determined in uncomplicated pregnancies
only. For these analyses we selected women with uncom-
plicated pregnancies by excluding pregnancies with a non-
live born child, preterm birth, a small for gestational age
newborn, hypertensive disorders or pre-existing hyperten-
sion, resulting in a population of n = 7015; definitions of
complicated pregnancies have previously been described in
detail [31–33].
Since hCG is secreted by trophoblasts, the number of
trophoblast cells (approximated by the weight of the pla-
centa) may influence total hCG levels. Therefore, we in-
vestigated whether placental weight at birth is associated
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with total hCG MoM levels. Furthermore, it is speculated
that hCG plays a role in hyperemesis gravidarum, and
therefore we investigated if specific hyperemesis gravi-
darum symptoms (reflux/belching, nausea or vomiting) are
associated with total hCG MoM levels.
For covariates with missing data, multiple imputation
according to the Markov Chain Monte Carlo method was
used [34]. Five imputed data sets were created and pooled
for analyses. Maternal smoking, education, ethnicity, BMI,
parity and child gender were added to the model (missing
due to non-response in 12.6, 9.0, 5.4 and\2 %, respec-
tively). Furthermore, we added gestational age at time of
blood sampling, maternal age, and pregnancy complica-
tions as prediction variables only. No significant differ-
ences in descriptive characteristics were found between the
original and imputed datasets. Confidence intervals for US
RRs were created using bootstrap analyses with 1000
sample draws. The associations between maternal or fetal
characteristics and total hCG (MoM) levels were analyzed
by ANOVA and linear regression. Univariate analyses
were adjusted for gestational age at blood sampling and
multivariate analyses were adjusted for gestational age at
blood sampling, maternal age, smoking, BMI, education
level, maternal ethnicity, parity and child gender. To
achieve normal distribution for statistical testing, total hCG
values and MoM values were transformed by the natural
logarithm. The above analyses were performed using Sta-
tistical Package of Social Sciences version 21.0 for Win-
dows (SPSS Inc. Chicago, IL, USA). The associations
between pregnancy characteristics and total hCG MoM
levels depicted in the figures were assessed by ordinary
least squares fitting functions with restricted cubic splines
from the RMS library in R statistical package, version 3.03.
Results
Descriptive characteristics of the study population are
shown in Supplemental Table 1. Population-based, gesta-
tional age specific median and RR values for total hCG are
shown in Table 1 and model-based reference centile curves
are depicted in Fig. 1. Throughout gestation, total hCG
levels showed a peak in the 9th and 10th week of gestation,
after which a steady decline was observed.
Reference range comparisons
Pregnancy dating based on ultrasound is determined by
fetal size. Considering that hCG is associated with fetal
growth, we studied if gestational age specific hCG RRs are
different when gestational age is determined by ultrasound
(US RRs) or based on the first day of the last menstrual
period (LMP RRs). As is shown in Table 2, compared to
US RRs, LMP RR levels showed a shift to the left with
particularly lower levels for the median and lower limit
levels. For RRs determined in women with an uncompli-
cated pregnancy, only small differences with the popula-
tion-based approach were seen (Supplemental Table 2).
Supplemental Table 3 shows the median, and upper or
lower limit cut-off values for total hCG as calculated by the
previous non-parametric method compared to the same cut-
off values derived from a model-based approach. In general,
the model-based RRs were in the low-normal region of the
non-parametric RRs 95 % confidence interval. However,
overall there was not a statistically significant differences
between the cut-off values from both methods. Furthermore,
the z-scores derived from the model were highly correlated
with the commonly used Multiple of Median (MoM) values
(Standardized b = 0.919; data not shown).
Determinants of hCG
Figure 2 shows the association between maternal or fetal
characteristics and total hCG levels adjusted for gestational
week by multiple of median (MoM) transformation. Taken
together, the determinants depicted explained 6.7 % of the
variability with maternal smoking, BMI, parity and child
gender as the main determinants of total hCG (MoM) levels.
Compared to non-smokers, smokers on average had lower
total hCG values (-6.299 ± 642 IU/L; P\ 0.001) and the
effects of smoking on total hCG levels were dose dependent.
The effect of smoking on total hCG levels was modified by
gestational age (interaction term ‘smoking(yes)’ * ‘gesta-
tional age at blood sampling’: P = 0.10; with corresponding
b for total hCG MoM level for the first, second (wk
13.1–16.5) and third tertile of gestational age of -0.143,
-0.189 and -0.186, respectively). The total hCG values of
women who stopped smoking after a positive pregnancy test
were similar to non-smokers.Women within the highest BMI
quintile on average had a substantially lower mean total hCG
level compared to women within the first quintile (average
difference 9369 ± 729 IU/L, P\ 0.001; Supplemental
Table 4) and mean total hCG level differences according to
parity and child gender ranged between approximately
2000–4000 IU/L. These results remained similar after mul-
tivariate correction for potential confounders (Supplemental
Table 4). We also investigated the women who were ex-
cluded for these analyses and found that IVF treatment and
twin pregnancies were associated with higher mean total
hCG (MoM) levels (Supplemental Table 5).
As is shown in Fig. 3, an increase in placental weight
was associated with an increase in total hCG MoM values.
In the multivariate model, placental weight remained as-
sociated with total hCG levels. Although addition of pla-
cental weight to the model did reduce the strength of the
associations between BMI, smoking, parity, ethnicity or
1060 T. I. M. Korevaar et al.
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fetal gender and total hCG (MoM) levels, these asso-
ciations remained highly significant. Furthermore, an in-
creasing frequency of self-reported hyperemesis
gravidarum symptoms (i.e. reflux/belching, nausea or
vomiting) was associated with an increase in total hCG
MoM values (Supplemental Table 6).
Table 1 Gestational age
specific, total population
reference ranges for hCG in
8065 women
Gestational
week
N Median Minimum 2.5th 97.5th Maximum
\9 32 59.973 455 2.305 94.251 142.584
9 50 75.494 22.655 24.310 125.882 129.909
10 106 74.655 16.080 24.370 137.697 163.393
11 255 62.493 10.340 23.669 129.242 187.852
12 790 56.004 8.105 22.846 114.774 164.125
13 1.418 52.367 4.618 23.272 109.990 166.478
14 1.069 47.267 5.925 20.494 105.369 144.054
15 800 37.303 4.834 14.262 82.506 122.037
16 594 29.614 7.512 11.159 80.656 132.084
17 455 24.426 5.637 8.294 69.447 151.558
18 354 20.693 3.822 6.637 50.109 75.993
19 271 17.609 3.895 5.022 52.640 90.628
20 389 17.354 3.128 5.342 43.692 78.841
21 530 15.088 1.542 4.213 42.892 73.485
22 330 16.174 2.559 3.689 44.548 86.541
23 165 12.415 1.957 2.390 43.379 65.192
24 134 13.739 2.511 4.067 45.031 49.392
25 79 14.749 3.354 3.847 53.383 63.166
[25 244 13.852 518 2.228 58.125 74.719
hCG reference range values were calculated according to a population-based approach in the whole study
population, after exclusion of women with IVF treatment (N = 38), twin pregnancy (N = 90) or TOP
pregnancies (N = 2)
Fig. 1 Gestational age specific reference ranges for total hCG levels
during pregnancy. Total hCG reference range values were calculated
according to a (semi) parametric 2.5th–97.5th percentiles by
GAMLSS modelling in a population-based approach among the
entire study population, after exclusion of women with IVF treatment
(N = 38), twin pregnancy (N = 90) or TOP pregnancies (N = 2).
Colored lines depict the gestational age specific centiles for total hCG
levels. Grey area depict areas with higher uncertainty due to small
numbers (N per week\40 before week 9 and after week 24)
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Discussion
Total hCG values and RR cut-offs during pregnancy vary
depending on different methodological as well as indi-
vidual factors. In the current study we determined a
population-based gestational age specific RR for total hCG
during pregnancy and we demonstrate that these RRs differ
depending on the methodology used to determine gesta-
tional age. Furthermore, we show that maternal smoking,
BMI, parity, ethnicity, child gender and placental weight
are factors associated with total hCG levels and that in-
creasing severity of reflux/belching, nausea and vomiting
symptoms was associated with increasing total hCG levels.
We determined RRs for total hCG amongst the whole
population and when we compared such RRs with RRs
calculated in women with uncomplicated pregnancies we
found only small, negligible differences. RRs were also
calculated using a model-based approach. Although there
was an overall trend for lower estimates as compared to the
non-parametric methods, these differences overall did not
reach statistical significance. Future analyses should deter-
mine whether these differences in cut-off values influence
the associations of total hCG with pregnancy complications
or whether there are consequences for the identification of
women with a clinically relevant increased risk of other
adverse outcomes. However, considerable differences were
present between the US RRs and the LMP RRs. Overall, US
RRs were higher compared to LMP RRs and as such it
seems likely that US RRs are affected by the effects of hCG
on fetal growth. This fits with observations that hCG levels
are negatively associated with fetal growth [35, 36].
Moreover, this suggests that pregnancy dating by ultra-
sound, which is considered the gold standard, might be less
reliable in women with relatively high or low levels of hCG.
We show that BMI is one of the most influential de-
terminants of total hCG levels, exhibiting an inverse as-
sociation. Previous studies have shown a similar
association between hCG and BMI, and some aneuploidy
screening programs use BMI corrected values in order to
increase testing performance [18, 19, 37]. The patho-
physiology behind these associations is currently unclear.
BMI has been positively associated with placental weight
and increasing placental weight is associated with in-
creasing hCG levels in this study. This may suggest that
higher placental weight in women with high BMI levels
may compensate the negative association between BMI
and hCG. However, in a subset of women in which pla-
cental weight was known (n = 5851), the association be-
tween BMI and total hCG MoM levels remained similar
after adjustment for placental weight (b ± SE per
ln(MoM) change; unadjusted: -0.019 ± 0.001 vs. adjust-
ed: -0.020 ± 0.001; data not shown) suggesting separate
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mechanisms in the effects on hCG. The pathways via
which this effect occurs remain to be elucidated and a
potential role for adipokines or inflammatory markers
should be considered [38–40].
Similar to previous studies, smoking was associated
with lower hCG levels in the current study as well. How-
ever, we are the first to show that women who stopped
smoking when the pregnancy test was positive had similar
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interval. Analyses were performed after exclusion of women with IVF
treatment (N = 38), twin pregnancy (N = 90) or TOP pregnancies
(N = 2), and were adjusted for maternal age, smoking, BMI, parity,
education level, ethnicity and fetal gender
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Fig. 3 The relationship between placental weight and total hCG
MoM levels. Plots show the relationship between placental weight at
birth and total hCG MoM levels as predicted mean with 95 percent
confidence interval. Analyses were performed after exclusion of
women with IVF treatment (N = 38), twin pregnancy (N = 90) or
TOP pregnancies (N = 2; placental weight available in n = 5851)
and were adjusted for maternal age, smoking, BMI, parity, education
level, ethnicity and fetal gender. For uncomplicated pregnancies we
selected women’s first pregnancy registered in our database and
excluded pregnancies with a non-live born child, preterm birth, a
small for gestational age newborn, hypertensive disorder or pre-
existing hypertension resulting in a population of n = 7015 (with
placental weight available n = 4999)
Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study 1063
123
total hCG levels as non-smokers (Supplemental Table 4).
This indicates that discontinuation of smoking at the time
of known pregnancy may prevent the reduction in total
hCG levels seen amongst continuing smokers and that the
effects of smoking on total hCG levels will only become
apparent after a particular smoking duration (dose depen-
dency). Indeed, similar to findings by Ball et al. [41, 42],
the strength of the association between total hCG and
smoking increased with gestational age. Most likely, this
effect is a cumulative smoking effect considering that we
also found a strong dose-dependent association between the
number of cigarettes smoked and total hCG decrease. For
aneuploidy screening, usually utilizing b-hCG levels, nei-
ther the total effects of smoking nor the gestational age
dependent effects had a considerable impact on the out-
come [16, 41, 43]. Prenatal smoking has consistently been
associated with an increased risk of small for gestational
age children and low placental weight. It is likely that the
effects of prenatal smoking on birth weight of the newborn
are at least in part caused by a decrease in hCG levels as it
has been shown that prenatal smoking leads to an increase
in apoptosis of synctiotrophoblast cell layer [44]. Future
studies should investigate to what extent hCG contributes
to the changes in fetal growth and birth weight. Moreover,
given the unequivocal link between smoking and adverse
perinatal outcomes, the strong association between smok-
ing and total hCG levels is a clear demonstration of the
confounding potential of pregnancy characteristics in
studies investigating the relationship between hCG levels
and any clinical outcomes/measurements.
Interestingly, in particular the effects of smoking, but
also the effects of other characteristics seemed to be more
pronounced in our study compared to other studies [16–18,
20, 21, 43, 45]. This may be due to the fact that we de-
termined total hCG levels using an assay which detects the
vast majority of hCG variants [25] whereas most other
studies report the effects on b-hCG. In turn, this could
suggest that BMI, smoking, parity, ethnicity, child gender
and placental weight have differential effects on specific
types of hCG such as nicked or hyperglycosylated hCG.
To our knowledge, this is the only study which reports
RRs for total hCG during pregnancy apart from the
manufacturer of the assay that we used, which reported on
593 pregnant women [46]. Furthermore, we are the first to
report the associations between detailed maternal and fetal
characteristics and total hCG levels during pregnancy.
Access to an extensive database allowed us to compare
different methods of RR determinations and study the as-
sociation of various sparsely reported maternal/pregnancy
characteristics including placental weight and vomiting
symptomatology. We were, however, limited by the fact
that LMP and the menstrual cycle, placental weight and
vomiting symptoms were only available in a subset of
women. Also, the number of women with availability of
total hCG measurements varied for each gestational week
and therefore reference range determinations were not
equally reliable throughout gestation, particularly during
very early and the third trimester of pregnancy. Potential
differences in formulas used to determine gestational age
based on ultrasound data may also underlie some of our
results and warrant further research.
In conclusion, we provide data on total hCG reference
ranges during pregnancy from a large prospective popula-
tion-based cohort and identified that these may considerably
differ according to pregnancy dating methodology. Fur-
thermore, we found that total hCG differs according to ma-
ternal BMI, smoking, parity, ethnicity, child gender,
placental weight and hyperemesis gravidarum symptoms.
Our results suggest that the association between gestational
age, hCG and fetal growth can cause less reliable ultrasound
derived pregnancy dating, in particular in women with high
or low levels of hCG. These data underline the complex
relations between hCG, maternal and fetal factors, which
should be taken into account when studying pregnancy
complications. Our findings can serve as a reference for
various clinical research studies and warrant further research
on reference range determination for hCG during pregnancy.
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